Recombinant CD33 (Gemtuzumab Biosimilar) antibody
Quick Overview for Recombinant CD33 (Gemtuzumab Biosimilar) antibody (ABIN5668210)
Target
Antibody Type
Reactivity
Host
Clonality
Conjugate
Application
Clone
-
-
Purpose
- Anti-CD33 [hP67.6 (Gemtuzumab)], Human IgG4, kappa
-
Specificity
- Recognises human CD33.
-
Characteristics
-
Original Species of Ab: Human
Original Format of Ab: IgG4
-
Purification
- Protein A affinity purified
-
Purity
- > 98 % as determined by SDS-PAGE
-
Endotoxin Level
- Endotoxin is < 1.0 EU/mg as determined by the LAL method
-
Immunogen
- Gemtuzumab was generated by huminization of the murine P67.6 clone, raised against CD33-transfected FMY9S5 cells of human origin. CD33 is a transmembrane receptor expressed on predominantly on cells of the myeloid lineage, but it can also be found on some lymphoid cells.
-
Isotype
- IgG4 kappa
-
-
-
-
Application Notes
- A human IgG4 variant conjugated to derivative of the cytotoxic drug calicheamicin gamma 1, N-acetylcalicheamicin dimethyl hydrazide, has been used as a therapeutic against acute myeloid leukemia. This antibody may also be used in flow cytometry and immunofluorescence.
-
Restrictions
- For Research Use only
-
-
-
Concentration
- 1 mg/mL
-
Buffer
- PBS with 0.02 % Proclin 300.
-
Preservative
- ProClin
-
Precaution of Use
- This product contains ProClin: a POISONOUS AND HAZARDOUS SUBSTANCE which should be handled by trained staff only.
-
Storage
- 4 °C,-20 °C
-
Storage Comment
- Store at 4°C for up to 3 months. For longer storage, aliquot and store at -20°C.
-
-
- CD33 (Gemtuzumab Biosimilar)
-
Target Type
- Biosimilar
-
Background
- Siglec-3
-
UniProt
- P20138
Target
-